Monoclonal Antibodies Treatment
If you’ve tested positive for COVID-19, one of the first questions you may have is, What can I do to reduce the risk of getting sicker? The good news is, there are treatments that may reduce that risk. Depending on your age, health history, and how long you’ve had symptoms of COVID-19, you may qualify for a promising form of treatment for the disease. It’s called monoclonal antibody (mAb) treatment.
Some early evidence suggests that mAb treatment can reduce the amount of the SARS-CoV-2 virus (the virus that causes COVID-19) in a person's system. This amount is known as viral load. Having a lower viral load means you may have milder symptoms thereby decreasing the likelihood of you needing to stay in the hospital.
mAb treatment may help people who:
- Have a positive COVID-19 test, and had symptoms for 10 days or less
- Are at high risk of getting more serious symptoms
Getting Treatment with Better Health Pharmacy
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved products casirivimab/imdevimab for the treatment of mild to moderate coronavirus disease 2019 in adults and pediatric patients.
Before booking your appointment, please make sure you meet all the criteria below:
- Positive results of direct SARS-CoV-2 viral testing
- 12 years of age and older weighing at least 40 kg
- Symptomatic from SARS-CoV-2 ≤ 10 days of direct SARS-CoV-2 viral testing
- Are at high risk for progressing to severe COVID-19 and/or hospitalization. (must meet 1 or more of the below)
- Older age (for example age ≥65 years of age)
- Obesity or being overweight (for example, adults with BMI >25 kg/m2, or if age 12-17, have BMI ≥85th percentile for their age and gender based on CDC growth charts, https://www.cdc.gov/growthcharts/clinical_charts.htm)
- Pregnancy
- Chronic kidney disease
- Diabetes
- Immunosuppressive disease or immunosuppressive treatment
- Cardiovascular disease (including congenital heart disease) or hypertension
- Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma [moderate-to- severe], interstitial lung disease, cystic fibrosis and pulmonary hypertension)
- Sickle cell disease
- Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
- Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19))
Book Appointment Online